Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Phathom Pharmaceuticals, Inc. - Common Stock
(NQ:
PHAT
)
9.690
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Phathom Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
August 07, 2023
One of the safest sectors on the market is biotech. Here are three cheap biotech stocks to buy that are good options for investors.
Via
InvestorPlace
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the Firm
June 19, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Phathom Pharmaceuticals Announces FDA Acceptance of NDA Resubmission for Erosive GERD
June 12, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals Resubmits FDA Application For Acid Blocker, Raises $131M Via Equity
May 24, 2023
Via
Benzinga
Analyst Expectations for Phathom Pharmaceuticals's Future
May 11, 2023
Via
Benzinga
Where Phathom Pharmaceuticals Stands With Analysts
April 05, 2023
Via
Benzinga
Where Phathom Pharmaceuticals Stands With Analysts
March 13, 2023
Via
Benzinga
Phathom Pharmaceuticals Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
June 09, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Phathom, Reata, and Comerica and Encourages Investors to Contact the Firm
June 04, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
June 01, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
May 26, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
PHATHOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Phathom Pharmaceuticals, Inc. on Behalf of Phathom Stockholders and Encourages Investors to Contact the Firm
May 26, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock
May 23, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 23, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals Resubmits Erosive GERD New Drug Application to FDA
May 23, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
May 21, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
May 11, 2023
Via
Benzinga
Phathom Pharmaceuticals Reports First Quarter 2023 Results
May 10, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Phathom Pharmaceuticals Presents New Data at Digestive Disease Week® (DDW) 2023
May 09, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
April 16, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) Near the Top of Equities by Percentage Gain on 4/13
April 13, 2023
Via
Investor Brand Network
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
April 12, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Insiders Buying Phathom Pharmaceuticals And 2 Other Stocks
April 12, 2023
Although US stocks closed mixed on Tuesday, there were a few notable insider trades.
Via
Benzinga
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT
April 09, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 04, 2023
Via
Benzinga
Phathom Pharmaceuticals Announces Regulatory Update and Plans for 2023 Erosive Esophagitis and H. pylori Commercial Launch
April 04, 2023
From
Phathom Pharmaceuticals
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
March 09, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
March 24, 2023
On Friday, 469 companies hit new 52-week lows.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.